Digital Marketing Trends in Type 2 Diabetes

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

Digital Marketing Trends in Type 2 Diabetes Report Overview

Novo Nordisk’s Ozempic.com achieved the highest total traffic across type 2 diabetes (T2D) patient brand sites in the US, with over 23 million visitors between April 2022–March 2023, followed by Eli Lilly’s Trulicity.com and AstraZeneca’s Farxiga.com. The highest proportion of traffic to branded patient T2D websites originated from direct sources, followed by organic. Novo Nordisk’s Rybelsus.com had the highest proportion of direct traffic.

The Digital Marketing Trends in the Type 2 Diabetes research report assess key digital marketing metrics of pharma assets in Type 2 Diabetes (T2D), including branded websites for patients and healthcare professionals (HCPs), unbranded websites, and social media accounts. The report offers metrics on website traffic volume, engagement, source, digital display advertising (DDA), paid search engine optimization (SEO), and social media post interaction. Moreover, the countries analyzed in the report are the US, 4EU (Italy, France, Germany, and Spain), the UK, and Canada (EUCAN).

Key US Patient-Branded Websites ·       Ozempic.com

·       Trulicity.com

·       Farxiga.com

·       Jardiance.com

·       Mounjaro.com

·       Rybelsus.com

·       Januvia.com

Key US HCP Branded Websites ·       AstraZeneca’s Farxiga-hcp.com

·       Sanofi’s Toujeopro.com

·       AstraZeneca’s Bydureonhcp.com

·       Novo Nordisk’s Ozempicpro.com

Key EUCAN Branded Websites ·       Rybelsus.ca

·       Tresiba.ca

·       Fiasp.ca

·       Lilly-diabetes.de

Enquire & Decide Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase.

Major US Patient Branded Websites for Type 2 Diabetes

The major US patient-branded websites for Type 2 Diabetes are Ozempic.com, Trulicity.com, Farxiga.com, Jardiance.com, Mounjaro.com, Rybelsus.com, and Januvia.com. Januvia.com achieved the highest average visit duration and Eli Lilly’s Mounjaro.com had the most pages per visit, while Trulicty.com had the lowest bounce rate.

Traffic Share to Branded US T2D Patient Sites, April 2022 – March 2023 (%)

Traffic Share to Branded US T2D Patient Sites, April 2022 – March 2023 (%)

 For more insights into the total traffic share of the US patient-branded websites, download a free report sample

Major US HCP Branded Websites for Type 2 Diabetes

The major US HCP-branded websites for Type 2 Diabetes are AstraZeneca’s Farxiga-hcp.com, Sanofi’s Toujeopro.com, AstraZeneca’s Bydureonhcp.com, and Novo Nordisk’s Ozempicpro.com. AstraZeneca’s Farxiga-hcp.com achieved the highest total traffic across T2D HCP sites in the US, from April 2022 to March 2023, followed by Sanofi’s Toujeopro.com. Farixga-hcp.com also achieved the highest average visit duration, the highest pages per visit, and the lowest bounce rate.

Traffic Share to Branded US T2D HCP Sites, April 2022 – March 2023 (%)

Traffic Share to Branded US T2D HCP Sites, April 2022 – March 2023 (%)

For more insights into the total traffic share of the US HCP branded websites, download a free report sample

Top US Social Media Activity in Type 2 Diabetes

During April 2022–March 2023, several social media posts related to T2D were detected in the US on pharma corporate accounts, including from Novo Nordisk, Boehringer Ingelheim, and Eli Lilly. Among them, the post with the highest interaction was from Novo Nordisk’s Facebook account on Diabetes Awareness Month, promoting a video of a speaker describing how she took steps in taking care of an elderly patient with T2D.

Major EUCAN Branded Websites for Type 2 Diabetes

The major EUCAN-branded websites for Type 2 Diabetes are Rybelsus.ca, Tresiba.ca, Fiasp.ca, and Lilly-diabetes.de. Novo Nordisk’s Rybelsus.ca achieved the highest total traffic across T2D branded sites in EUCAN, from April 2022 to March 2023, followed by Novo Nordisk’s Tresiba.ca). Rybelsus.ca also achieved the highest average visit duration, while Tresiba.ca achieved the highest pages per visit and lowest bounce rate.

Traffic Share to Branded EUCAN T2D Sites, April 2022 – March 2023 (%)

Traffic Share to Branded EUCAN T2D Sites, April 2022 – March 2023 (%)

For more insights into the total traffic share of the EUCAN-branded websites, download a free report sample

Top EUCAN Social Media Activity in Type 2 Diabetes

During April 2022–March 2023, several social media posts related to T2D were detected on pharma corporate accounts in EUCAN, including Novo Nordisk, Eli Lilly, AstraZeneca, and Boehringer Ingelheim. The post with the most interaction was from Novo Nordisk’s Italian Facebook account, discussing the prevention of the occurrence of cardiovascular disease in people with T2D.

Scope

This report assesses key digital marketing metrics of pharma assets in type 2 diabetes (T2D), including branded websites for patients and healthcare professionals (HCPs), unbranded websites, and social media accounts. Metrics include website traffic volume, engagement, and source, digital display advertising (DDA), paid search engine optimization (SEO), and social media post interaction. Countries include the US, 4EU (Italy, France, Germany, and Spain), the UK, and Canada (EUCAN).

Reasons to Buy

  • Understand the digital marketing competitive landscape in T2D, with a view of leading patient and HCP branded assets across different regions.
  • See what tactics pharma companies are using to drive traffic to their T2D branded and unbranded assets for patients and HCPs, such as DDA and paid SEO.
  • Understand what sources of website traffic are generating the most visits to these assets, such as paid SEO, social media, or organic searches.
  • Compare top branded assets for patients by how they address and support different patient needs.
  • See what pharma social media accounts in T2D are the most active and achieving the most engagement.

Novo Nordisk
Eli Lilly
AstraZeneca
Sanofi
Boehringer Ingelheim

Table of Contents

Executive Summary

US Patient Branded Websites

US HCP Branded Websites

US Unbranded Websites

US Social Media

EUCAN Branded Websites

EUCAN Unbranded Websites

EUCAN Social Media

Appendix

Frequently asked questions

Digital Marketing Trends in Type 2 Diabetes thematic reports
Currency USD
$1,950

Can be used by individual purchaser only

$3,900

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Digital Marketing Trends in Type 2 Diabetes was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Digital Marketing Trends in Type 2 Diabetes in real time.

  • Access a live Digital Marketing Trends in Type 2 Diabetes dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.